Novel Compounds as CX3CR1Modulators for Treating Cardiovascular Diseases

Provided herein are novel compounds as CX3CR1 modulators, pharmaceutical compositions, use of such compounds in treating cardiovascular diseases, and processes for preparing such compounds.

Authors

Ram W. Sabnis (ORCID: https://orcid.org/0000-0001-7289-0581)

Publication Details

Journal: ACS Medicinal Chemistry Letters
Published: 2025-12-30
DOI: https://doi.org/10.1021/acsmedchemlett.5c00750
Primary Topic: Chemokine receptors and signaling
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Novel Compounds as CX3CR1Modulators for Treating Cardiovascular Diseases

Ram W. Sabnis

Dec 30, 2025

ACS Medicinal Chemistry Letters

Chemokine receptors and signaling

article

Novel Compounds as CX3CR1Modulators for Treating Cardiovascular Diseases

Ram W. Sabnis

December 30, 2025article en

Abstract

Provided herein are novel compounds as CX3CR1 modulators, pharmaceutical compositions, use of such compounds in treating cardiovascular diseases, and processes for preparing such compounds.

ACS Medicinal Chemistry LettersVol. 17(2)

Zero hunger

Openalex Percentile: Top 30%

Chemokine receptors and signaling

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Compounds as CX3CR1Modulators for Treating Cardiovascular Diseases — Ram W. Sabnis · ACS Medicinal Chemistry Letters (2025) | TGRS Research Map | TGRS